The best indicator for CDW Corporation (CDW)
We backtested 20 indicators across daily, weekly and hourly charts on real CDW Corporation (CDW) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
CCI
On the daily chart, this is the strongest risk-adjusted edge we found for CDW Corporation (CDW) over ~12.9 years — trailing buy-and-hold by 8.0% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | CCI ✓ | Daily | 9.9% | 0.61 | -39.9% | 74.2% | 62 | -8.0% |
| 2 | WaveTrend (8/6/4) ✓ | Daily | 11.4% | 0.61 | -42.3% | 74.0% | 50 | -6.5% |
| 3 | Bollinger Mean-Reversion ✓ | Daily | 8.1% | 0.55 | -39.6% | 82.1% | 56 | -9.8% |
| 4 | Donchian Midline | Weekly | 9.3% | 0.52 | -47.3% | 50.0% | 28 | -8.3% |
| 5 | Bollinger Mean-Reversion ✓ | Weekly | 9.5% | 0.61 | -30.3% | 75.0% | 12 | -8.1% |
| 6 | MACD ✓ | Daily | 7.4% | 0.46 | -46.9% | 46.3% | 123 | -10.5% |
| 7 | Bollinger Breakout ✓ | Weekly | 8.7% | 0.65 | -26.3% | 80.0% | 10 | -8.9% |
| 8 | Williams %R | Daily | 6.7% | 0.43 | -41.2% | 74.4% | 86 | -11.2% |
| 9 | Stochastic ✓ | Daily | 6.1% | 0.42 | -34.3% | 72.4% | 58 | -11.8% |
| 10 | Holy Grail Confluence ✓ | Daily | 6.0% | 0.41 | -33.7% | 78.9% | 19 | -11.9% |
| 11 | RSI Trend (>50) | Weekly | 6.7% | 0.41 | -53.0% | 41.4% | 29 | -11.0% |
| 12 | Donchian Midline | Daily | 5.9% | 0.38 | -48.3% | 45.9% | 157 | -12.0% |
| 13 | EMA 20/50 Cross | Daily | 5.7% | 0.37 | -57.0% | 46.7% | 30 | -12.2% |
| 14 | Rate of Change | Weekly | 5.1% | 0.36 | -55.8% | 61.9% | 42 | -12.5% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For CDW Corporation (CDW), CCI on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.